Application of nirmatrelvir/ritonavir for the treatment of severe COVID-19 in a 3-year-old child
Introduction: Nirmatrelvir/ritonavir (Paxlovid) is an effective antiviral drug for treating coronavirus disease 2019 (COVID-19) in adults. However, Paxlovid treatment of children, especially those who are under 12 years and with severe underlying diseases, is rare. Case report: A three-year-old C...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
The Journal of Infection in Developing Countries
2024-11-01
|
| Ráidu: | Journal of Infection in Developing Countries |
| Fáttát: | |
| Liŋkkat: | https://jidc.org/index.php/journal/article/view/18685 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|